Biology · Oct / Nov 2023 · Paper 21 · Question 6
YBI11
As printed in the paper
The question as text
6 A mimic octopus can change shape to look like other organisms. The photographs show a venomous sea snake, a mimic octopus looking like a venomous sea snake and a mimic octopus looking like a flat fish. venomous sea snake (Source: Reinhard Dirscherl / Alamy Stock Photo) mimic octopus looking like a venomous sea snake (Source: David Fleetham / Alamy Stock Photo) mimic octopus looking like a flat fish (Source: Hal Beral / VWPics / Alamy Stock Photo)
Read automatically from the paper; the printed page above is exact.
Show the answer and mark scheme
6(a)(i)[1]
accept species/octopus etc for organism
ignore animal
role of an organism in its {environment / habitat / ecosystem} (1)
ACCEPT niche includes all of the abiotic
and biotic aspects of the (organisms)
habitat (1)
6(a)(ii)[1]
accept phonetic spellings
anatomical / physiological (1)
accept anatomic
ignore physical
6(a)(iii)[2]
An answer that makes reference to the following points:
(looking like a flat fish) therefore {more likely to catch prey
accept {predators / prey} will not {see /
/ reduce risk of predation / camouflaged} (1)
recognise} them / hide from predators / blend
into environment / lure prey / enter flat
openings
accept they can get among flat fish to prey on
them
ignore reduce {competition / predation} from
flat fish
ignore hide unqualified
(looking like a venomous sea snake) reduced predation /
accept protection from {predators / sea snakes}
less likely to be eaten / predators would avoid venomous
increase survival chance
prey (1)
accept scare predators away / deter predators /
look like a predator instead of prey
ignore defending themselves with
venom/eq General Marking Guidance
All candidates must
receive
the
same
treatment. Examiners
must mark the first
candidate in exactly
the same way as they
mark the last.
Mark schemes should
be applied positively.
Candidates must be
rewarded
for
what
they have shown they
can do rather than
penalised
for
omissions.
Examiners
should
mark according to the
not
according
to
their
perception of where
the grade boundaries
may lie.
There is no ceiling on
achievement.
All
marks on the mark
should
be
used appropriately.
All the marks on the
are
designed
to
be
awarded.
Examiners
should always award
full marks if deserved,
i.e.
if
the
matches
the
scheme.
Examiners
should
also
be
prepared
to
award
zero
if
the
candidate’s response
is not worthy of credit
according to the mark
scheme.
Where
some
judgement
is
required,
schemes will provide
the
principles
by
which marks will be
awarded
and
exemplification
may
be limited.
When examiners are
in doubt regarding the
application
of
the
mark scheme to a
candidate’s response,
the team leader must
be consulted.
Crossed
out
work
should
be
marked
6(b)(i)[1]
The only correct answer is A control
B is not correct because the current painrelieving drug is used as a control
C is not correct because the current painrelieving drug is used as a control
D is not correct because the current painrelieving drug is used as a control
6(b)(ii)[4]
A description that makes reference to four of the following points:
(stage I) testing on healthy {people / volunteers} (without
accept computer modelling
cancer) (1)
accept testing on {human cells /
human tissues / animals}
(stage III) testing on {1000 to 3000 / large number of}
ignore patients unqualified
cancer patients (1)
ignore patients with {pain/ disease}
double blind trial (1) even if in stage II
accept description of double blind
analysis of results with (appropriate) statistical test / test for
accept peer review by scientists
significant difference / review by independent {scientists /
ignore {comparing results / analysis}
medics/FDA} (to see if work can progress to next stage) (1)
unqualified
identification of appropriate {concentrations / dosage} (1)
accept {identification of / rule out}
{side effects / adverse reactions /
toxicity / how drug is metabolised}
6(c)[4]
An answer that makes reference to four of the following points:
idea that both drugs provide pain relief / current drug provides
Piece together
35 hours of pain relief / tetrodoxin provides 460(+) hours of pain
accept {same trend / largest decrease} {at
relief / few patients experience the longest pain relief (1)
the beginning / suitable stated time}
accept linear decrease for current pain
reliving drug whereas {nonlinear /
exponential} decrease for tetrodoxin
tetrodoxin more effective pain relief drug / converse (1)
accept tetrodoxin {has longer period of
pain relief / lasts longer / is better pain
relief drug} / converse
awarding mp2 means mp1 as well
consideration of subjective nature of {pain / duration of pain
e.g. different people have different pain
relief} (1)
tolerance
{small sample size / no repeats / no SD / no error bars / no
accept carried out on (only) {100 to 500}
statistical test} linked to {validity/reliability/ significance} (1)
(cancer) patients / each group contained
(only) {50 to 250) (cancer) patients
ignore no information about sample size
no information on age / sex / lifestyle / type of cancer /
accept gender
dosage / side effects etc (1)
Make a free account to save your answers and see your weak topics and ask the AI why a wrong answer is wrong.

